We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTIS icon
1001
Otis Worldwide
OTIS
$27.4B
$446K ﹤0.01%
4,500
– –
CPRI icon
1002
Capri Holdings
CPRI
$1.77B
$444K ﹤0.01%
25,100
-11,900
-32% -$196K
PBR icon
1003
Petrobras
PBR
$121B
$438K ﹤0.01%
35,000
– –
INGR icon
1004
Ingredion
INGR
$6.38B
$434K ﹤0.01%
3,200
– –
UYSCU
1005
UY Scuti Acquisition Corp Units
UYSCU
$433K ﹤0.01%
42,200
– –
UTI icon
1006
Universal Technical Institute
UTI
$2.08B
$430K ﹤0.01%
12,700
-800
-6% -$25.1K
LEA icon
1007
Lear
LEA
$7.19B
$427K ﹤0.01%
4,500
-700
-13% -$61.5K
FTNT icon
1008
Fortinet
FTNT
$112B
$426K ﹤0.01%
4,031
– –
SRI icon
1009
Stoneridge
SRI
$209M
$415K ﹤0.01%
59,000
– –
APOG icon
1010
Apogee Enterprises
APOG
$850M
$415K ﹤0.01%
+10,213
New +$421K
TFX icon
1011
Teleflex
TFX
$5.85B
$414K ﹤0.01%
3,500
– –
VVX icon
1012
V2X
VVX
$2.62B
$413K ﹤0.01%
8,500
-2,500
-23% -$119K
VSXY
1013
Victoria's Secret
VSXY
$6.64B
$412K ﹤0.01%
+22,269
New +$435K
DNUT icon
1014
Krispy Kreme
DNUT
$543M
$407K ﹤0.01%
140,000
+68,000
+94% +$237K
GSRTR
1015
DELISTED
GSR III Acquisition Corp Right
GSRTR
$407K ﹤0.01%
+59,570
New +$222K
CWEN icon
1016
Clearway Energy Class C
CWEN
$5B
$406K ﹤0.01%
12,700
– –
CDRE icon
1017
Cadre Holdings
CDRE
$1.32B
$404K ﹤0.01%
12,671
– –
HYAC
1018
DELISTED
Haymaker Acquisition Corp 4
HYAC
$402K ﹤0.01%
36,200
– –
REPX icon
1019
Riley Exploration Permian
REPX
$770M
$402K ﹤0.01%
+15,307
New +$404K
STWD icon
1020
Starwood Property Trust
STWD
$6.12B
$401K ﹤0.01%
20,000
– –
FORM icon
1021
FormFactor
FORM
$8.11B
$400K ﹤0.01%
+11,629
New +$353K
WEX icon
1022
WEX
WEX
$6.11B
$397K ﹤0.01%
+2,701
New +$363K
HMN icon
1023
Horace Mann Educators
HMN
$2.1B
$396K ﹤0.01%
+9,222
New +$388K
CAAS icon
1024
China Automotive Systems
CAAS
$131M
$384K ﹤0.01%
94,022
– –
RYN icon
1025
Rayonier
RYN
$6.49B
$383K ﹤0.01%
18,103
– –
39 40
41
42 43

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.